0001209191-21-062491.txt : 20211102 0001209191-21-062491.hdr.sgml : 20211102 20211102180202 ACCESSION NUMBER: 0001209191-21-062491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andersen Jill CENTRAL INDEX KEY: 0001891047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40703 FILM NUMBER: 211372816 MAIL ADDRESS: STREET 1: 303 WYMAN STREET STREET 2: SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adagio Therapeutics, Inc. CENTRAL INDEX KEY: 0001832038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851403134 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 303 WYMAN STREET STREET 2: SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 530-3600 MAIL ADDRESS: STREET 1: 303 WYMAN STREET STREET 2: SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-01 0 0001832038 Adagio Therapeutics, Inc. ADGI 0001891047 Andersen Jill 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 0 1 0 0 Chief Legal Officer, Secretary Stock Option (Right to Buy) 30.65 2021-11-01 4 A 0 514863 0.00 A 2031-10-31 Common Stock 514863 514863 D One quarter (1/4) of the option shall vest on November 1, 2022, and thereafter, the remainder of the option shall vest in 36 equal monthly installments on the 1st day of each month, subject to the Reporting Person's continuous service on each vesting date. /s/ Dorothy Vinsky, Attorney-in-Fact 2021-11-02